Western blot analysis examined the expression of ACLY in four CCA cell lines (Supplementary Figure S3A), and we selected RBE, HUCCT1, and TFK1 for shRNA-mediated knockdown experiments due to their higher expression levels. Here, ACLY is linked to cholangiocarcinoma.